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As a fat-soluble vitamin, Vitamin D is a necessary hormone to maintain 
normal physiological activities of the body. In recent years, vitamin D has 
been considered as a new neuroendocrine-immunomodulatory hormone, 
and researchers have paid more attention to the study of immune regulatory 
mechanism. It is not only related to calcium and phosphorus metabolism, 
bone metabolism and other important metabolic mechanisms of the body, 
but also closely related to the immune regulation mechanism of the body. 
Vitamin D deficiency caused by many factors can play a certain role in the 
development of autoimmune diseases. In this paper, the related mechanisms 
of vitamin D affecting autoimmune diseases were reviewed, with a view to 
expound the close correlation between vitamin D and autoimmune diseases, 
so as to find new diagnosis and treatment approaches for clinical autoim-

















National College Students Innovation and Entrepreneurship Project (Project No.: 202011810019). 
1. Introduction
Vitamin D (VitD) is a fat-soluble vitamin necessary for human growth and development, Which can-not be synthesized by itself, but can be obtained 
through food or through the skin absorption of ultraviolet 
isomerism. The main regulatory activity in the human 
body is 1, 25dihydroxyvitamin D3 [1, 25(OH)2D3] [1] ,not 
only plays an important role in calcium and phosphorus 
metabolism, bone metabolism, cell growth and differenti-
ation, also play an inhibitory effect in a variety of autoim-
mune diseases [2] . A large number of studies have shown 
that vitamin D deficiency is closely related to the occur-
rence and development of autoimmune diseases, tumors, 
cardiovascular and cerebrovascular diseases, diabetes and 
other diseases [3-8]. At the same time Vit D also play an 
important role in anti-inflammatory and immune regula-
tion, reduction of vitamin D levels in many autoimmune 
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disease patients is widely reported [9-10]. Based on this, a 
review on the research progress of vitamin D and autoim-
mune diseases is presented.
2. Immunomodulatory Effects of Vitamin D 
Vitamin D plays an indispensable role in the immune sys-
tem. Because immune cells express vitamin D receptor 
(Vitamin D Receptor, VDR), vitamin D can be combined 
with VDR in immune cells to affect the biological activity 
of vitamin D metabolic pathway to regulate innate and 
non-adaptive immunity. The main factor of its vitamin D 
metabolism pathway to regulate the body is its active form 
[125-(OH)2-Vit D 3], its effect on immune regulation is 
bidirectional, through the degree of expression can not 
only improve the body's own immunity, but also inhibit 
abnormal strong immune response [11].Active vitamins D 
reduce the production of autoimmune systemic diseases 
by regulating innate and adaptive immunity, autoimmune 
diseases such as systemic lupus erythematosus and rheu-
matoid arthritis have been validated in mouse models [12-13]. 
In innate immunity 1,25-(OH)2-VitD3 mediates further 
monocyte differentiation into macrophages, Causes mac-
rophages to produce immunosuppressive prostaglandin 
E2, Inhibition of macrophage secretion of inflammatory 
factors and chemokines; At the other hand, it can directly 
regulate the expression of anti-microbial peptide gene and 
enhance the  of anti-infection ability. In adaptive immu-
nity1, 25-(OH) 2-VitD3 can affect the differentiation of 
activated T cells and inhibit Th1 cell response, may also 
indirectly inhibit the proliferation of activated B cells by 
regulating Th cells [14] . 
3. Vitamin D and Autoimmune Diseases
3.1 Vitamin D and Autoimmune Thyroid Disease
Autoimmune thyroid disease (Autoimmune Thyroid Dis-
eases, AITD) is an organ-specific autoimmune disease. 
Its main pathological types are Graves disease (Basedow 
Disease, GD) and Hashimoto's thyroiditis (Hashimoto 
Thyroiditis, HT).
Clinical studies have shown that autoimmune thyroid 
disease is associated with vitamin D deficiency in recent 
years [15-17], KE and other studies of GD patients show that 
normal people have higher levels of vitamin D than GD pa-
tients. Tamer studies show that, The deficiency of vitamin 
D in HT patients makes its incidence much higher than that 
of healthy control population [16]; Studies by He Jing et al 
on patients diagnosed with AIDT and vitamin D deficiency 
show that, Vitamin D supplements can reduce antibody 
levels in AIDT patients, Has been relieved and even sig-
nificantly improved [17], All these studies have one thing 
in common: people with low levels of vitamin D, Higher 
incidence of autoimmune diseases and timely vitamin sup-
plementation D help patients improve autoimmune diseas-
es. The pathogenesis of AITDs is also regulated by genetic 
factors. Abnormal expression of genes related to vitamin D 
metabolic pathway leads to uncontrolled autoimmune mon-
itoring and abnormal proliferation of autoantibodies, which 
leads to the production of autoimmune thyroid diseases [17-18]. 
This shows that vitamin D plays a certain role in the occur-
rence and development of AITD.
3.2 Vitamin D and Rheumatoid Arthritis
RA (Rheumatoid Arthritis, RA) is a chronic autoimmune 
inflammatory disease, characterized by autoantibody pro-
duction, chronic synovial inflammation, progressive joint 
destruction and deformity [19-20]. RA is a devastating and 
common autoimmune disease, A lifetime prevalence rate 
of 1% worldwide, Female, smoking and family history 
of the disease are more likely to suffer from [21] disease. 
Although the main cause of RA is unclear, But there have 
been reports that, The development of rheumatoid arthritis 
is caused by genetic and environmental factors, Vitamin D 
metabolic pathway gene VDR is one of the important genes 
of RA susceptibility [22-23].In recent years, Single nucleo-
tide polymorphism (Single Nucleotide Polymorphism,) by 
VDR gene SNP) the search for RA risk related genes has 
become a research hotspot and VDR gene polymorphisms 
may affect the occurrence and development of vitamin D 
by affecting the function and serum level. Tizaoui K et al. 
Meta-analysis of 1,703 cases and 2,635 healthy controls 
in 12 case-controls yielded results in homozygotes, In 
the dominant and allele comparison model, There was a 
significant correlation between VDR polymorphism TaqI 
and RA diseases, suggesting that our vitamin D related 
gene polymorphisms play a role in the occurrence and 
development of RA. Vitamin D receptor (Vitamin D Re-
ceptor,) simultaneously VDR) it is also closely related to 
the occurrence and development of RA. And VDR, are 
widely expressed in immune cells such as dendritic cells, 
macrophages, activated T lymphocytes and B lympho-
cytes, The results suggest that the immunomodulatory 
effect of vitamin D can be by regulating factors acting on 
immune cells [24] . By combining with VDR, Vitamin D 
inhibits the increased activity of immune cells involved 
in adaptive autoimmune responses, by inhibiting inflam-
matory response to regulate immune homeostasis [25]. 
And then abnormal levels of vitamin D can disrupt that 
balance, By inhibiting proliferation of Th1 cells, So that 
bone loss, eventually leading to osteopenia and osteoporo-
sis [26]. To sum up, Vitamin D down to the molecular level, 
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Up to the receptor protein has obvious correlation with 
rheumatoid arthritis.
4. Vitamin D and Systemic Lupus Erythema-
tosus
SLE (Systemic Lupus Erythematosus, SLE) is mediat-
ed by autoimmunity, of autoimmune diseases involving 
multiple organs and systems[27] . The pathogenesis of the 
disease involves immune, environmental, hormonal and 
genetic factors, Lack of specificity, it’s usually chronic or 
occult, at present, the pathogenesis is complex and there is 
no effective treatment [28]. SLE is common among women 
of childbearing age, and the disease has the characteristics 
of repeated delay, easy recurrence, multi-system involve-
ment, at the same time, the clinical treatment of hormones 
and immunosuppressants will cause a serious burden on 
the physical and mental health of patients [29-30]. Although 
the pathogenesis of SLE remains unclear, some studies 
have shown that vitamin D plays an important role the 
occurrence and development of SLE [30]. A number of clin-
ical meta-analyses show that, the decrease in vitamin D in 
SLE patients is widespread, the metabolic rate of vitamin 
D decomposition in patients was faster than that in healthy 
people [31]. Islam MA et al .34 case-control studies (2265 
SLE patients and 1846 healthy controls) showed that reg-
ular vitamin supplementation D help SLE the treatment 
of patients. And compared to healthy people, the serum 
vitamin D level of SLE patients was obviously low [32]. 
Through the above research, we know that there is a cer-
tain correlation between vitamin D and SLE disease activ-
ity, Provide data support for the prevalence of vitamin D 
deficiency in SLE, Hint that we can regularly supplement 
vitamin D as part of the health management plan. 
5. Conclusion
To sum up, vitamin D, as an immunomodulatory hor-
mone, plays an important immunomodulatory role in im-
mune diseases. As the relationship between vitamin D and 
autoimmune diseases is deeply studied, it is a research 
direction to understand the pathogenesis of autoimmune 
diseases from the gene level, and it can provide a new way 
for the treatment and prevention of autoimmune diseases. 
For a better understanding of the role of vitamin D in au-
toimmune diseases, we need high-quality evidence-based 
medical evidence and broader prospective studies to pro-
vide a new diagnosis and treatment for autoimmune dis-
eases.
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